What is the current Needle Biopsy market size?

The current Needle Biopsy market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Needle Biopsy market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Needle Biopsy market?

Key drivers include rising cancer incidence, technological advancements, and growing healthcare expenditure.

What challenges does the Needle Biopsy market face?

Challenges include high costs, limited reimbursement, and stringent regulatory requirements.

Which regions are leading the Needle Biopsy market?

North America and Europe are leading regions, driven by advanced healthcare infrastructure.

Who are the top companies in the Needle Biopsy market?

Top companies include Medtronic, Boston Scientific, and Cook Medical, offering innovative solutions.

What future opportunities exist in the Needle Biopsy market?

Future opportunities include emerging markets, innovative technologies, and growing demand for minimally invasive procedures.

How is technology impacting the Needle Biopsy market?

Technological advancements, such as imaging guidance, are improving diagnostic accuracy and driving market growth.

What is the current regulatory landscape for the Needle Biopsy market?

The regulatory landscape is stringent, with FDA and CE mark approvals required for product commercialization.

What is the future outlook for the Needle Biopsy market?

The future outlook is positive, with growing demand and technological advancements driving market expansion.

Needle Biopsy Growth, Trends & Forecast Outlook 2033

Needle Biopsy by Type (/> Fine-Needle Aspiration Biopsy, Core Needle Biopsy, Vacuum-Assisted Biopsy, Image-Guided Biopsy), by Application (/> Tumor, Infection, Inflammation), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 114

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Pages: 114

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Needle Biopsy Market Size | CAGR 7.8 Forecast 2033

Needle Biopsy Growth, Trends & Forecast Outlook 2033

🏭 Healthcare🌍 Global

Pages: 114

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Pages: 114

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Needle Biopsy Market Overview

The Needle Biopsy market refers to the global industry involved in the development, manufacturing, and distribution of needle biopsy products, which are medical devices used to collect tissue or cell samples from the body for diagnostic purposes. As the Needle Biopsy market size is expected to witness significant growth, driven by the increasing prevalence of chronic diseases and the rising demand for minimally invasive diagnostic procedures, the growth outlook and market forecast are crucial for industry stakeholders. The global Needle Biopsy market size was approximately $677 million in 2021 and is expected to reach $1.4 billion by 2026, growing at a CAGR of 10.3% during the forecast period from 2026 to 2033, driven by technology shifts, regulatory approvals, and consumer behavior trends that are shaping the industry expansion.

Loading chart…

The key forces shaping the industry include the increasing adoption of minimally invasive diagnostic procedures, advancements in biopsy technology, and the rising demand for personalized medicine. The largest region in the Needle Biopsy market is North America, while the fastest-growing region is Asia-Pacific, driven by the increasing prevalence of chronic diseases and the growing demand for diagnostic procedures in these regions. As the Needle Biopsy market continues to evolve, industry stakeholders must stay informed about the latest trends and developments to stay ahead of the competition.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.19 billion
Growth rate	CAGR of 7.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Boston Scientific; Cook Medical; Carefusion; Hologic; Cardinal Health; Medax; CR Bard; MöLler Medical; Becton, Dickinson And Company; Kompass; Hakko
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Needle Biopsy market is poised for significant growth, driven by increasing demand for minimally invasive diagnostic procedures. Understanding the dynamics of this market is crucial for stakeholders to navigate its complexities and capitalize on emerging opportunities.

Growth Drivers2 items

Advancements in needle biopsy technology have improved the accuracy and efficiency of diagnostic procedures, leading to increased adoption rates and contributing to the growth forecast of the Needle Biopsy market size.

The rising prevalence of chronic diseases, such as cancer, has created a surge in demand for diagnostic tools like needle biopsy, further fueling the growth of the Needle Biopsy market.

Restraints2 items

High costs associated with needle biopsy procedures and the need for specialized equipment and trained personnel are significant restraints to the widespread adoption of these diagnostic tools, potentially impacting the growth forecast.

Regulatory hurdles and stringent approval processes for new needle biopsy technologies can delay market entry and hinder the growth of the Needle Biopsy market size.

Opportunities2 items

Emerging markets present significant opportunities for the Needle Biopsy market, as increasing healthcare spending and a growing demand for diagnostic services drive the need for needle biopsy technologies.

The integration of needle biopsy with artificial intelligence and other digital health technologies offers opportunities for innovation and expansion of the Needle Biopsy market.

Challenges2 items

Ensuring the quality and safety of needle biopsy procedures while maintaining cost-effectiveness is a significant challenge facing manufacturers and healthcare providers in the Needle Biopsy market.

The competitive landscape of the Needle Biopsy market is intense, with numerous players competing for market share, which can challenge the growth and profitability of individual companies.

Market Segmentation

Loading chart…

The Needle Biopsy market can be segmented based on Type, which includes Fine-Needle Aspiration Biopsy and Core Needle Biopsy. Fine-Needle Aspiration Biopsy is a type of biopsy where a small sample of cells is removed using a fine needle, while Core Needle Biopsy involves removing a small sample of tissue using a larger needle. Understanding the Needle Biopsy segmentation by type is crucial to determine the market size and growth prospects of each subtype.

The Needle Biopsy market can also be segmented based on Application, which includes Breast Biopsy, Liver Biopsy, Kidney Biopsy, and Other Applications. Breast Biopsy is the largest application segment, driven by the increasing incidence of breast cancer. The application segment contributes significantly to the overall Needle Biopsy market size, and analyzing the market taxonomy by application helps in identifying the lucrative opportunities and trends in the market.

Needle Biopsy Segmentation Breakdown9 items

Type

/> Fine-Needle Aspiration Biopsy

Core Needle Biopsy

Vacuum-Assisted Biopsy

Image-Guided Biopsy

Application

/> Tumor

Infection

Inflammation

Regional Insights

Loading chart…

The Needle Biopsy market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of advanced medical technologies, favorable policies, and significant investments in healthcare infrastructure.

In North America, key drivers include a mature ecosystem, high demographics awareness, and established infrastructure. Europe is driven by adoption of minimally invasive procedures, policies supporting healthcare innovation, and a strong ecosystem. Asia Pacific's growth is fueled by rising demographics, increasing investments in healthcare, and improving infrastructure. Latin America and Middle East & Africa are expected to experience moderate growth, driven by developing ecosystem maturity, growing adoption, and increasing investments in healthcare.

Regional Drivers4 items

North America: mature ecosystem, high demographics awareness, established infrastructure

Europe: adoption of minimally invasive procedures, policies supporting healthcare innovation, strong ecosystem

Asia Pacific: rising demographics, increasing investments in healthcare, improving infrastructure

Latin America and Middle East & Africa: developing ecosystem maturity, growing adoption, increasing investments in healthcare

Competitive Landscape

The Needle Biopsy market is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, and product innovation. Key competitive levers include regulatory approvals, certifications, and strategic partnerships. Understanding the Needle Biopsy competitive landscape is crucial for companies to navigate this complex market. Global players tend to dominate the market, but local companies are also gaining traction, particularly in emerging economies.

Companies in the Needle Biopsy market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, and R&D investments. However, they face challenges such as margin pressure, compliance costs, and commoditization. To stay competitive, companies focus on technology innovation, service model differentiation, and channel strength. The following companies have notable strategies:

Boston Scientific: regional expansion

Cook Medical: premium pricing

Hologic: innovation pipeline

Cardinal Health: local manufacturing

Becton, Dickinson And Company: OEM tie-ups

CR Bard: vertical integration

Key Needle Biopsy Companies11 items

Boston Scientific

Cook Medical

Carefusion

Hologic

Cardinal Health

Medax

CR Bard

MöLler Medical

Becton, Dickinson And Company

Kompass

Hakko

Market Ecosystem

The Needle Biopsy ecosystem encompasses a complex network of stakeholders, spanning upstream technology providers and suppliers to downstream end users. This ecosystem can be broadly segmented into three stages: upstream, where raw materials and components are sourced; midstream, where integrators and manufacturers create the biopsies; and downstream, where channels and end users interact. Value is created and captured through the development, production, and distribution of needle biopsy products, with each stage influencing the overall efficiency and effectiveness of the ecosystem.

Raw material/component suppliers — provide core materials

OEMs / manufacturers — produce needle biopsy devices

Technology providers — develop underlying technologies

System integrators / EPCs — integrate biopsy systems

Distributors / channel partners — facilitate product distribution

Service providers / after-sales — offer maintenance and support

End users / buyers — utilize needle biopsy products

In the Needle Biopsy ecosystem, control points are primarily held by technology providers, manufacturers, and regulators, who influence adoption through innovation, production, and standards. Dependency risks arise from input constraints, such as the availability of raw materials, and regulatory approvals, which can impact the production and distribution of needle biopsy devices. Conducting a thorough value chain analysis can help identify potential bottlenecks and switching costs, as well as highlight opportunities for partnerships and interoperability. The ecosystem's dynamics can vary by region, with different areas having distinct regulatory frameworks, market demands, and competitive landscapes.

Recent Industry Insights

The Needle Biopsy industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between key players have focused on improving diagnostic accuracy and expanding product portfolios. Notable mergers and acquisitions have also taken place, leading to enhanced market consolidation and increased competition. Furthermore, several product and technology launches have emphasized the importance of minimally invasive procedures, driving growth in the market.

Additionally, regulatory changes have played a crucial role in shaping the Needle Biopsy market landscape. A shift in consumer and enterprise trends towards personalized medicine has fueled the demand for advanced biopsy techniques. The market has also seen notable funding rounds and expansions, with companies investing heavily in research and development to stay ahead of the curve and capitalize on emerging Needle Biopsy industry trends.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Needle Biopsy market outlook. The market exhibits moderate attractiveness, driven by increasing demand for minimally invasive diagnostic procedures. The competitive intensity is high, with key players investing in research and development to improve biopsy needle technology. The long-term outlook is promising, with emerging innovations in robotic-assisted biopsy systems and image-guided techniques. However, the demand–supply balance may be affected by fluctuations in healthcare expenditure and regulatory policies. Key risk factors include intense competition, stringent regulatory requirements, and technological advancements that may disrupt the market.

11 items

1. Executive Summary

2. Needle Biopsy Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Needle Biopsy Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Needle Biopsy Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.1. /> Fine-Needle Aspiration Biopsy

6.1.2. Core Needle Biopsy

6.1.3. Vacuum-Assisted Biopsy

6.1.4. Image-Guided Biopsy

6.2. Global Needle Biopsy Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.2.1. /> Tumor

6.2.2. Infection

6.2.3. Inflammation

6.3. Global Needle Biopsy Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Needle Biopsy Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Needle Biopsy Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Needle Biopsy Market Competition by Key Manufacturers

8.1. Global Needle Biopsy Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Needle Biopsy: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Boston Scientific

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Cook Medical

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Carefusion

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Hologic

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Cardinal Health

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Medax

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. CR Bard

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. MöLler Medical

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Becton, Dickinson And Company

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Kompass

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Hakko

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Needle Biopsy Market

Figure 4: Global Needle Biopsy Market: Drivers

Figure 5: Global Needle Biopsy Market: Challenges

Figure 6: Global Needle Biopsy Market: Trends

Figure 7: Global Needle Biopsy Market: Opportunity

Figure 8: Global Needle Biopsy Market: Restraint

Figure 9: Global Needle Biopsy Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Needle Biopsy Market Value (USD Million) By Region

Figure 15: Global Needle Biopsy Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Type

Figure 19: Global Market Share (%) By Type (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Application

Figure 21: Global Market Share (%) By Application (2032)

Figure 22: Global Needle Biopsy Market Value (USD Million) By Region

Figure 23: Global Needle Biopsy Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

75 items

Table 1: Market Segmentation Analysis

Table 2: Global Needle Biopsy Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Needle Biopsy Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Needle Biopsy Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Needle Biopsy Market Value (USD Million) By Region

Table 10: Global Needle Biopsy Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Type

Table 13: North America Market Value (USD Million) (2020-2024) By Application

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Type

Table 16: Europe Market Value (USD Million) (2020-2024) By Application

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Type

Table 22: South America Market Value (USD Million) (2020-2024) By Application

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 26: Global Needle Biopsy Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Needle Biopsy Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Needle Biopsy Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Boston Scientific Basic Information And Sales Area

Table 31: Boston Scientific. Products Portfolio

Table 32: Cook Medical Basic Information And Sales Area

Table 33: Cook Medical. Products Portfolio

Table 34: Carefusion Basic Information And Sales Area

Table 35: Carefusion. Products Portfolio

Table 36: Hologic Basic Information And Sales Area

Table 37: Hologic. Products Portfolio

Table 38: Cardinal Health Basic Information And Sales Area

Table 39: Cardinal Health. Products Portfolio

Table 40: Medax Basic Information And Sales Area

Table 41: Medax. Products Portfolio

Table 42: CR Bard Basic Information And Sales Area

Table 43: CR Bard. Products Portfolio

Table 44: MöLler Medical Basic Information And Sales Area

Table 45: MöLler Medical. Products Portfolio

Table 46: Becton, Dickinson And Company Basic Information And Sales Area

Table 47: Becton, Dickinson And Company. Products Portfolio

Table 48: Kompass Basic Information And Sales Area

Table 49: Kompass. Products Portfolio

Table 50: Hakko Basic Information And Sales Area

Table 51: Hakko. Products Portfolio

Table 52: Global Market Value (USD Million) (2025-2032) By Type

Table 53: Global Market Share (%) By Type (2032)

Table 54: Global Market Value (USD Million) (2025-2032) By Application

Table 55: Global Market Share (%) By Application (2032)

Table 56: Global Needle Biopsy Market Value (USD Million) By Region

Table 57: Global Needle Biopsy Market Share (%) By Region (2025-2032)

Table 58: North America Market Value (USD Million) (2025-2032) By Country

Table 59: North America Market Value (USD Million) (2025-2032) By Type

Table 60: North America Market Value (USD Million) (2025-2032) By Application

Table 61: Europe Market Value (USD Million) (2025-2032) By Country

Table 62: Europe Market Value (USD Million) (2025-2032) By Type

Table 63: Europe Market Value (USD Million) (2025-2032) By Application

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 65: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 67: South America Market Value (USD Million) (2025-2032) By Country

Table 68: South America Market Value (USD Million) (2025-2032) By Type

Table 69: South America Market Value (USD Million) (2025-2032) By Application

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 71: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 73: Research Programs/Design For This Report

Table 74: Key Data Information From Secondary Sources

Table 75: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Needle Biopsy Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.19 billion
Growth rate	CAGR of 7.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Boston Scientific; Cook Medical; Carefusion; Hologic; Cardinal Health; Medax; CR Bard; MöLler Medical; Becton, Dickinson And Company; Kompass; Hakko
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options